A Comparison of Immediate Coronary Angioplasty with Intravenous Streptokinase in Acute Myocardial Infarction
New England Journal of MedicinePublished 11 March 1993Open access
Felix Zijlstra, Menko Jan de Boer, Jan C.A. Hoorntje, Stoffer Reiffers, Johan H. C. Reiber, Harry Suryapranata
Citations1,295
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Immediate angioplasty after acute myocardial infarction was associated with a higher rate of patency of the infarct-related artery, a less severe residual stenotic lesion, better left ventricular function, and less recurrentMyocardial ischemia andinfarction than was intravenous streptokinase.
Abstract
Immediate angioplasty after acute myocardial infarction was associated with a higher rate of patency of the infarct-related artery, a less severe residual stenotic lesion, better left ventricular function, and less recurrent myocardial ischemia and infarction than was intravenous streptokinase.
Keywords
Medicine
New England Journal of MedicinePrevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
2,738 Citations1980Marcus A. DeWood, Julie Spores +5 more
Total coronary occlusion is frequent during the early hours of transmural infarction and decreases in frequency during the initial 24 hours, suggesting that coronary spasm or thrombus formation with subsequent recanalization or both may be important in the evolution ofinfarction.
CirculationThrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
2,252 Citations1987James H. Chesebro, Genell L. Knatterud +8 more
In patients with acute myocardial infarction, rt-PA elicited reperfusion in twice as many occluded infarct-related arteries as compared with SK at each of seven serial observations during the first 90 min after onset of treatment.
New England Journal of MedicineComparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
1,019 Citations1989The TIMI Study Group*
The ejection fraction and the incidence of death in the two groups were similar during the hospital period and total mortality within the first 6 days and at 42 days was also similar; the latter comparison was considered statistically significant according to the study criteria.
CirculationIncidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.
931 Citations1988Patrick W. Serruys, Hans E. Luijten +8 more
The incidence of restenosis proved to be progressive to at least the third month for all except NHLBI criterion II, and the lack of overlap between the different restenotic criteria applied affirms the arbitrary nature of angiographic definitions currently in use.
The LancetMEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction
911 Citations1990GRUPPOITALIANOPERLOSTUDIODELL
SK and tPA appear equally effective and safe for use in routine conditions of care, in all infarct patients who have no contraindications, with or without post-thrombolytic heparin treatment.
CirculationAssessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.
832 Citations1985Johan H. C. Reiber, Patrick W. Serruys +7 more
It is concluded that the biological variations are a source of major concern and that further attempts toward standardization of the angiographic procedure are seriously needed.
The LancetTHROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY
660 Citations1988M. L. Simoons
There seems to be no need for immediate angiography and PTCA in patients with acute myocardial infarction treated with rTPA, with a lower incidence of recurrent ischaemia, bleeding complications, hypotension, and ventricular fibrillation after non-invasive therapy.
Journal of the American College of CardiologyEarly thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survival
504 Citations1986Maarten L. Simoons, Patrick W. Serruys +10 more
New England Journal of MedicineA Prospective Randomized Clinical Trial of Intracoronary Streptokinase versus Coronary Angioplasty for Acute Myocardial Infarction
503 Citations1986William W. O’Neill, GERALD C. TIMMIS +9 more
Angioplasty is significantly more effective in alleviating the underlying coronary stenoses, and this may result in more effective preservation of ventricular function after therapy, which is concluded to produce similar rates of early coronary reperfusion during evolving transmural myocardial infarction.
New England Journal of MedicineThe Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction
459 Citations1985Kennedy Jw, Ritchie Jl +4 more
It is concluded that intracoronary streptokinase reduces one-year mortality among patients with acute myocardial infarction, but this improvement occurs only among those in whom thrombolysis results in coronary artery reperfusion.
CirculationConsequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.
418 Citations1990E. Magnus Ohman, Robert M. Califf +8 more
Reocclusion of the infarct-related artery after successful reperfusion is associated with substantial morbidity and mortality rates and new strategies in the postinfarction period need to be developed to prevent reocclusion.
HeartEffect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial.
296 Citations1992D P de Bono, Maarten L. Simoons +8 more
Concomitant intravenous heparin improves coronary patency in patients with alteplase, and whether this can be translated into improved clinical benefit needs to be to be tested in a larger trial.
CirculationEvaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group.
277 Citations1991Robert M. Califf, Eric J. Topol +8 more
Immediate postoperative administration of aspirin (324 mg) improves early graft patency and, with continued usage, protects against further occlusion up to 1 year after CABG.
Journal of the American College of CardiologyLong-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands
220 Citations1989Maarten L. Simoons, Jeroen Vos +5 more
The salutary effects of thrombolytic therapy appear to be the result of myocardial salvage, particularly in patients with inferior wall infarction and those with greater than or equal to 90% stenosis of the infarct-related vessel at discharge.
Journal of the American College of CardiologyStatus of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy
159 Citations1987Bruce F. Waller, Donald Rothbaum +8 more
CirculationLeft ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials.
123 Citations1990Robert M. Califf, Lynn Harrelson-Woodlief +1 more
A composite clinical end point that includes, in order, severity of adverse outcome death, hemorrhagic stroke, nonhemorrhagic strokes, poor ejection fraction, reinfarction, heart failure, and pulmonary edema may be useful to detect true therapeutic benefit in reperfusion trials without necessitating greater than 20-30,000 patient enrollment.
Developments in cardiovascular medicineQuantitative coronary arteriography: equipment and technical requirements
78 Citations1993Johan H. C. Reiber, Pieter M. J. van der Zwet +5 more
It has been shown that by virtue of modifications in the edge detection software to correct for the limited resolution of the X-ray imaging chain, vessel sizes down to 0.66 mm can be measured accurately and precisely.
CirculationCatheterization laboratory events and hospital outcome with direct angioplasty for acute myocardial infarction.
75 Citations1990Joel K. Kahn, Barry D. Rutherford +6 more
To assess the safety of direct infarct angioplasty without antecedent thrombolytic therapy, catheterization laboratory and hospital events were assessed in consecutively treated patients with infarctions involving the left anterior descending, right, and circumflex coronary arteries.
Journal of the American College of CardiologySudden paradoxic clinical deterioration during angioplasty of the occluded right coronary artery in acute myocardial infarction
67 Citations1989Gerald M. Gacioch, Eric J. Topol
Patients with right coronary artery occlusion had a higher incidence of life-threatening complications during angioplasty than did patients with left anterior descending artery Occlusion, and angiopLasty was initially successful in achieving TIMI grade 2 or 3 flow.
International journal of cardiac imagingA new approach for the automated definition of path lines in digitized coronary angiograms
57 Citations1990Pieter M. J. van der Zwet, Ibraim Pinto +2 more
The LancetTHERAPEUTIC TRIALS IN CORONARY THROMBOSIS SHOULD MEASURE LEFT VENTRICULAR FUNCTION AS PRIMARY END-POINT OF TREATMENT
47 Citations1988RobinM. Norris, HarveyD. White
Since one of several thrombolytic agents will be effective in conjunction with one or more myocardial protective agents, many trials will be required, and it may be more appropriate in future studies to measure left ventricular function rather than mortality as the principal end-point.
CirculationBalloon angioplasty for acute myocardial infarction. Was it buried alive?
25 Citations1990Bernhard Meier
In the setting of acute myocardial infarction, balloon angioplasty was initially used as a complementary measure in patients with failure or incomplete success of intracoronary thrombolysis with streptokinase, and quickly became the preferred and primary treatment in many centers equipped for emergency coronary angiography and angiopLasty.
Seminars in Nuclear MedicineUse of radionuclide measurements of left ventricular function for prognosis in patients with coronary artery disease
23 Citations1987Robert H. Jones
Radionuclide angiocardiography during rest and exercise provides useful assessment of patients before and after coronary artery bypass grafting.
Seminars in Nuclear MedicineRadionuclide cineangiography in acute myocardial infarction: Role in prognostication
14 Citations1987Jeffrey Borer, David S. Miller +3 more
Seminars in Nuclear MedicineFunctional imaging of the heart
5 Citations1987Robert J. Boudreau, Merle K. Loken
Functional images produced from the time-activity curves of individual pixels in the gated blood-pool study have been shown to be useful in delineating atrioventricular borders in both the left and right sides of the heart.